CD4 and neoplasm: At the time of tumor response initiation (i.e., post 3 IV injection), a higher level of tumor infiltration by CD4 T-cells was observed in the high-dose Lipo-MP-LPS group, but not in the low-dose group, compared to control group (p < 0.005) (Figure 5A).